Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by StockingUp21on May 12, 2021 2:10pm
137 Views
Post# 33183987

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I said nothing negative of antibe

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I said nothing negative of antibe

it's nice you know they have a big list of pharma to talk to. More important, how is discussion going? What conclusion can be drawn right now? 

Only person who looks fool is you for being trigger over discussion of why this is junk right now. 

 


Stoxxhp wrote:

Jefnan1 wrote: I was on here about a year ago. Have no idea who he is. My point is that his comments about what I originally said were illogical in my opinion as to the current share price


You damn fool!
How can you make such an asinine comment.
You want to complain about share price and in the same sentence say "who cares about partnership target list and the progress of those discussions?

Those partnership discussions and the eventual signing of a partner is, at this point, the sole outcome of what's going to move the share price.

I don't have 1/10 of your shares?
Do you have more than 270,000 shares?

And guess what else, the earth is not flat, just in case you're in that group of people who think that every scientist and astronaut in the world is in some collusion to trick you into believing otherwise.

Facts matter.
You should absolutely care, and understand why the share price has not moved.

You damn fool




<< Previous
Bullboard Posts
Next >>